Follow
shai izraeli
shai izraeli
Professor, Head of the Division of Pediatric Hematology Oncology Schneider Children's Medical Center
Verified email at clalit.org.il
Title
Cited by
Cited by
Year
Childhood acute lymphoblastic leukemia: progress through collaboration
CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ...
Journal of Clinical Oncology 33 (27), 2938-2948, 2015
9772015
The MLL recombinome of acute leukemias in 2017
C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, ...
Leukemia 32 (2), 273-284, 2018
6832018
The MLL recombinome of acute leukemias in 2013
C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ...
Leukemia 27 (11), 2165-2176, 2013
5662013
New insights to the MLL recombinome of acute leukemias
C Meyer, E Kowarz, J Hofmann, A Renneville, J Zuna, J Trka, ...
Leukemia 23 (8), 1490-1499, 2009
5182009
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non–small-cell lung carcinoma
D Lebanony, H Benjamin, S Gilad, M Ezagouri, A Dov, K Ashkenazi, ...
Journal of clinical oncology 27 (12), 2030-2037, 2009
5112009
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
C Shochat, N Tal, OR Bandapalli, C Palmi, I Ganmore, G te Kronnie, ...
Journal of Experimental Medicine 208 (5), 901-908, 2011
4152011
The landscape of somatic mutations in Down syndrome–related myeloid disorders
K Yoshida, T Toki, Y Okuno, R Kanezaki, Y Shiraishi, A Sato-Otsubo, ...
Nature genetics 45 (11), 1293-1299, 2013
4072013
Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002
J Stary, M Zimmermann, M Campbell, L Castillo, E Dibar, S Donska, ...
Journal of clinical oncology 32 (3), 174-184, 2014
4052014
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ...
The Lancet 372 (9648), 1484-1492, 2008
3982008
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report …
L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ...
Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010
3912010
The public repository of xenografts enables discovery and randomized phase II-like trials in mice
EC Townsend, MA Murakami, A Christodoulou, AL Christie, J Köster, ...
Cancer cell 29 (4), 574-586, 2016
3322016
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21
L Rainis, D Bercovich, S Strehl, A Teigler-Schlegel, B Stark, J Trka, ...
Blood 102 (3), 981-986, 2003
3192003
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
TD Buitenkamp, S Izraeli, M Zimmermann, E Forestier, NA Heerema, ...
Blood, The Journal of the American Society of Hematology 123 (1), 70-77, 2014
2942014
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
S Malinge, S Izraeli, JD Crispino
Blood, The Journal of the American Society of Hematology 113 (12), 2619-2628, 2009
2892009
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children …
G Cario, M Zimmermann, R Romey, S Gesk, I Vater, J Harbott, ...
Blood, The Journal of the American Society of Hematology 115 (26), 5393-5397, 2010
2852010
IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
M Stanulla, E Dagdan, M Zaliova, A Möricke, C Palmi, G Cazzaniga, ...
Journal of Clinical Oncology 36 (12), 1240-1249, 2018
2622018
The expression of three genes in primary non–small cell lung cancer is associated with metastatic spread to the brain
H Grinberg-Rashi, E Ofek, M Perelman, J Skarda, P Yaron, M Hajdúch, ...
Clinical Cancer Research 15 (5), 1755-1761, 2009
2502009
The SIL gene is required for mouse embryonic axial development and left–right specification
S Izraeli, LA Lowe, VL Bertness, DJ Good, DW Dorward, IR Kirsch, ...
Nature 399 (6737), 691-694, 1999
2371999
MiR-125 in normal and malignant hematopoiesis
L Shaham, V Binder, N Gefen, A Borkhardt, S Izraeli
Leukemia 26 (9), 2011-2018, 2012
2072012
STIL is required for centriole duplication in human cells
J Vulprecht, A David, A Tibelius, A Castiel, G Konotop, F Liu, F Bestvater, ...
Journal of cell science 125 (5), 1353-1362, 2012
2002012
The system can't perform the operation now. Try again later.
Articles 1–20